Treatment principles in advanced colorectal cancer

Australian and New Zealand Journal of Surgery

Volumn 66, Issue 4, 1996, Pages 202-205

  Zalcberg, J R ^a   Friedlander, M L ^b   Collopy, B T ^c   Barton, M ^d   Gray, B ^e  

^a AUSTIN HEALTH   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d WESTMEAD HOSPITAL   (Australia)

^e ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Chemotherapy; Metastatic colorectal cancer; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID;

ADJUVANT THERAPY; AUSTRALIA; COLORECTAL CANCER; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER METASTASIS; REVIEW; SURGICAL TECHNIQUE;

EID: 0030006259     PISSN: 00048682     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-2197.1996.tb01164.x     Document Type: Review

References (30)

1. Moertel CG, Fleming TR, MacDonald JS et al. Levamisole and fluorouracil for adjuvant therapy of resected colon cancer. N. Engl. J. Med. 1990; 332: 352-8.
2. Krook JE, Moertel CG, Gunderson LL et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N. Engl. J. Med. 1991; 324: 709-15.
3. Daly JM, Kemeny N. Therapy of colorectal hepatic metastases. In: DeVita VT, Hellman D, Rosenberg SA (eds). Important Advances in Oncology. Philadelphia: JB Lippincott, 1986: 251-68.
4. Poon MA, O'Connell MJ, Moertel CG et al. Biochemical modulation of Fluorouracil: Evidence of significant improvement of survival and quality of life in patients with advanced colorectal cancer. J. Clin. Oncol. 1989; 7: 1407-17.
5. Glimelius B, Hoffman K, Graf W, Pahlman L, Sjoden PO. Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer. Cancer 1994, 73; 556-62.
6. Scheithauer W, Rosen H, Kornek G et al. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ 1993; 306: 752-5.
7. Allan-Mersh TJ, Earlam S, Fordy C, Abrams K, Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastasis. Lancet 1994; 344: 1255-60.
8. Nordic Gastrointestinal Tumour Adjuvant Therapy Group. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer. J. Clin. Oncol. 1992; 10: 904-11.
9. Arbuck SG. Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancer. Cancer 1989; 63: 1036-44.
10. Mini E, Morrison BA, Bertino JB. Cytotoxicity of floxuridine and 5-fluorouracil in human T-lymphoblast leukaemia cells: Enhancement by leucovorin. Cancer Treat. Reports 1987; 71: 381-9.
11. Piedbois P, Buyse M. What can we learn from a meta-analysis of trials testing the modulation of 5FU by leucovorin? Advanced colorectal meta-analysis project. Ann. Oncol. 1993; 4 (Suppl. 2): 515-19.
12. Kemeny N, Daly J, Reschman B, Geller N, Bolet J, Oderman P. Intrahepatic or systemic infusion of fluorodeoxyundine in patients with liver metastases from colorectal cancer. Ann. Intern. Med. 1987; 107: 459-65.
13. Rougier P, Hay JM, Olivier JM et al. A controlled multicenter trial of intrahepatic chemotherapy vs standard palliative treatment for colorectal liver metastases [abstract]. Proc. Am. Soc. Clin. Oncol. 1990; 9: 104.
14. Zalcberg J. Phase II trial of Tomudex, a new thymidylate synthase inhibitor in metastatic colorectal cancer [abstract]. Proceedings of the Clinical Oncological Society of Australia. 20th Annual Scientific Meeting 1993; p.63.
15. Shimada Y, Yoshino M, Wakui A et al. Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. J. Clin. Oncol. 1993; 11: 909-13.
16. Loeffler JS, Shrieve DC. What is appropriate therapy for a patient with a single brain metastasis? Int. J. Radiat. Oncol. Biol. Phys. 1994; 29: 915-17.
17. James RD, Johnson RJ, Eddleston B, Zheng GL, Jones JM. Prognostic factors in locally recurrent rectal carcinoma treated by radiotherapy. Br. J. Surg. 1983; 70: 469-72.
18. Villalon AH, Green D. The use of radiotherapy for pelvic recurrence following abdominoperineal resection of carcinoma of the rectum: A 10 year experience. Aust. N.Z. J. Surg. 1981; 51:149-51.
19. Danjoux CE, Gelber RD, Catton GE, Klassen DJ. Combination chemoradiotherapy for residual recurrent or inoperable carcinoma of the rectum: ECOG study (est 3276). Int. J. Radiat. Oncol. Biol. Phys. 1995; 11: 765-71.
20. Cummings BJ, Rider WD, Harwood AR, Kean TJ, Thomas GM. Radical external beam radiation therapy for adenocarcinoma of the rectum. Dis. Colon Rectum 1983; 26: 30-6.
21. Cummings BJ. Rectal cancer. In: Dobelbower RR Jr (ed.) Gastrointestinal Cancer: Radiation Therapy. Berlin: Springer-Verlag, 1990; 179-215.
22. Masters A, Stegar AC, Brown SG. Role of interstitial therapy in the treatment of liver cancer. Br. J. Surg. 1991; 78: 518-23.
23. Safi F, Link KH, Beger H. Is follow up of colorectal cancer patients worthwhile? Dis. Colon Rectum 1993; 36: 636-42.
24. Goligher J. Treatment of carcinoma of the colon, treatment of carcinoma of the rectum. In: Surgery of the Anus, Rectum and Colon, 5th edn. London: Bailliere Tindall, 1984: 485-779.
25. Cady B, McDermott WV. Major hepatic resection for metachronous metastases from colon cancer. Ann. Surg. 1984; 201: 204-9.
26. Hughes K, Scheele J, Sugarbaker PH. Surgery for colorectal cancer metastatic to the liver. Surg. Clin. North Amer. 1989; 69: 339-59.
27. Kinsella TJ. The role of radiotherapy alone and combined with infusional chemotherapy for treating liver metastases. Semin. Oncol. 1983; 10: 215-22.
28. Ravikumar TS, Kane R, Cady B et al. A 5-year study of cryosurgery in the treatment of liver tumours. Arch. Surg. 1991; 126: 1520-4.
29. Giovannini M, Seitz J-F. Ultrasound-guided percutaneous alcohol injection of small liver metastases. Cancer 1994; 73: 294-7.
30. Amin Z, Brown SG, Lees WR. Local treatment of colorectal liver metastases: A comparison of interstitial laser photocoagulation and percutaneous alcohol injection. Clin. Radiol. 1993; 48: 166-71.